On Monday, Acelyrin Inc (NASDAQ: SLRN) opened lower -4.00% from the last session, before settling in for the closing price of $2.75. Price fluctuations for SLRN have ranged from $1.85 to $7.86 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 53.22% at the time writing. With a float of $73.01 million, this company’s outstanding shares have now reached $100.45 million.
Considering the fact that the conglomerate employs 83 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Acelyrin Inc (SLRN) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Acelyrin Inc is 27.51%, while institutional ownership is 76.07%. The most recent insider transaction that took place on Mar 17 ’25, was worth 49,354. In this transaction Chief Executive Officer of this company sold 17,986 shares at a rate of $2.74, taking the stock ownership to the 671,753 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Chief Legal Officer sold 3,913 for $2.74, making the entire transaction worth $10,737. This insider now owns 121,587 shares in total.
Acelyrin Inc (SLRN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.22% per share during the next fiscal year.
Acelyrin Inc (NASDAQ: SLRN) Trading Performance Indicators
Check out the current performance indicators for Acelyrin Inc (SLRN). In the past quarter, the stock posted a quick ratio of 18.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.86 in the next quarter and is forecasted to reach -2.01 in one year’s time.
Technical Analysis of Acelyrin Inc (SLRN)
Compared to the last year’s volume of 2.36 million, its volume of 0.93 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 49.69%. Additionally, its Average True Range was 0.14.
During the past 100 days, Acelyrin Inc’s (SLRN) raw stochastic average was set at 17.15%, which indicates a significant decrease from 49.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.44% in the past 14 days, which was lower than the 104.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.30, while its 200-day Moving Average is $4.21. Nevertheless, the first resistance level for the watch stands at $2.75 in the near term. At $2.85, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.93. If the price goes on to break the first support level at $2.57, it is likely to go to the next support level at $2.49. Should the price break the second support level, the third support level stands at $2.39.
Acelyrin Inc (NASDAQ: SLRN) Key Stats
There are currently 100,710K shares outstanding in the company with a market cap of 265.87 million. Presently, the company’s annual sales total 0 K according to its annual income of -381,640 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -48,550 K.
